نتایج جستجو برای: topoisomerase inhibitors

تعداد نتایج: 194843  

Journal: :Molecular biology of the cell 2003
Juneth Joaquin Partridge Joseph Onofrio Lopreiato Martin Latterich Fred Eliezer Indig

We report a novel nucleolar interaction between the AAA ATPase p97/VCP and the Werner protein (WRNp), a member of the RecQ helicase family. p97/VCP mediates several important cellular functions in eucaryotic cells, including membrane fusion of the endoplasmic reticulum and Golgi and ubiquitin-dependent protein degradation. Mutations in the WRN gene cause Werner syndrome, a genetic disorder char...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1995
Hashimoto Chatterjee Berger

Topoisomerase I-directed agents are now in Phase I and II clinical trials and show great promise as potentially important agents for cancer chemotherapy. Because of their mechanism of action they may also be potential mutagens; however, their mutagenicity and oncogenicity still remain to be elucidated. We have previously shown that VP-16, a topoisomerase II-directed agent, induces sister chroma...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1987
L Yang M S Wold J J Li T J Kelly L F Liu

We examined the roles of DNA topoisomerases in the replication of simian virus 40 (SV40) DNA in a cell-free system composed of an extract from HeLa cells supplemented with purified SV40 tumor antigen. When the activities of both topoisomerase I (EC 5.99.1.2) and topoisomerase II (EC 5.99.1.3) in the extract were blocked with specific inhibitors or antibodies, DNA synthesis was decreased by a fa...

پایان نامه :دانشگاه آزاد اسلامی - دانشگاه آزاد اسلامی واحد علوم دارویی - دانشکده داروسازی 1393

با توجه به حیاتی بودن نقش آنزیم topo ii در چرخه سلولی، این آنزیم میتواند هدف درمانی مهمی در شیمی درمانی سرطان باشد. فلوروکینولون ها به عنوان مهارکننده های آنزیم توپوایزومراز (ژیراز) باکتری به خوبی شناخته شده اند و اخیرا نیز نشان داده شده است که توان مهار توپوایزومراز ii یوکاریوتیکها را هم دارند. در این راستا در این پایان نامه ترکیبات جدیدی از فلوروکینولونها به منظور مهار آنزیم توپوایزومراز انسا...

Journal: :Molecular cancer therapeutics 2014
Annett Maderer Stanislav Plutizki Jan-Peter Kramb Katrin Göpfert Monika Linnig Katrin Khillimberger Christopher Ganser Eva Lauermann Gerd Dannhardt Peter R Galle Markus Moehler

3-Indolyl and 3-azaindolyl-4-aryl maleimide derivatives, called moguntinones (MOG), have been selected for their ability to inhibit protein kinases associated with angiogenesis and induce apoptosis. Here, we characterize their mode of action and their potential clinical value in human colorectal cancer in vitro and in vivo. MOG-19 and MOG-13 were characterized in vitro using kinase, viability, ...

Journal: :International Journal of Molecular Sciences 2021

Heat shock protein 90 (HSP90) plays an essential role in lung adenocarcinoma, acting as a key chaperone involved the correct functioning of numerous highly relevant drivers this disease. To end, HSP90 inhibitors have emerged promising therapeutic strategies, even though responses to them been limited date. Given need maximize treatment efficacy, objective study was use isobaric tags for relativ...

Journal: :Molecular pharmacology 2008
Hong Liang Xing Wu Jack C Yalowich Brian B Hasinoff

After the identification of a new lead bisphenol compound that had good topoisomerase IIalpha (EC 5.99.1.3) inhibitory activity, a series of bisphenol analogs were synthesized and tested to identify the structural features that were responsible for their activity. The bisphenols represent a new structural class of topoisomerase II inhibitor that potently inhibited the growth of Chinese hamster ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Anand G Patel Silvana B De Lorenzo Karen S Flatten Guy G Poirier Scott H Kaufmann

PURPOSE Poly(ADP-ribose) polymerase (PARP) inhibitors are undergoing extensive clinical testing for their single-agent activity in homologous recombination (HR)-deficient tumors and ability to enhance the action of certain DNA-damaging agents. Compared with other PARP inhibitors in development, iniparib (4-iodo-3-nitrobenzamide) is notable for its simple structure and the reported ability of it...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Wanqing Liu Lijun He Jacqueline Ramírez Mark J Ratain

PURPOSE: MDM2 is a key negative regulator of the p53 signaling pathway. We aimed to evaluate the inter-relationships between MDM2 SNP309, mRNA expression, amplification, and TP53 mutations, as well as their correlations with responsiveness to MDM2 inhibitors and other commonly used cytotoxic drugs tested in the NCI-60 cancer cell panel. EXPERIMENTAL DESIGN: SNP309 was genotyped in the NCI-60 ca...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید